Growth Metrics

Verastem (VSTM) Selling, General & Administrative (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 1.32 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -37.00 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 2.17 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 493.70 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -1.52 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 647.70 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 322.55 Mn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn 22.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 22.30 Mn
Dec 31, 2025 24.44 Mn
Sep 30, 2025 21.01 Mn
Jun 30, 2025 20.67 Mn
Mar 31, 2025 15.02 Mn
Dec 31, 2024 10.78 Mn
Sep 30, 2024 12.28 Mn
Jun 30, 2024 10.22 Mn
Mar 31, 2024 10.35 Mn
Dec 31, 2023 8.64 Mn
Sep 30, 2023 7.36 Mn
Jun 30, 2023 7.40 Mn
Mar 31, 2023 7.33 Mn
Dec 31, 2022 6.11 Mn
Sep 30, 2022 6.42 Mn
Jun 30, 2022 6.51 Mn
Mar 31, 2022 5.93 Mn
Dec 31, 2021 5.66 Mn
Sep 30, 2021 5.52 Mn
Jun 30, 2021 6.71 Mn
Mar 31, 2021 6.22 Mn
Dec 31, 2020 7.10 Mn
Sep 30, 2020 20.61 Mn
Jun 30, 2020 15.44 Mn
Mar 31, 2020 19.60 Mn
Dec 31, 2019 23.73 Mn
Sep 30, 2019 22.15 Mn
Jun 30, 2019 29.30 Mn
Mar 31, 2019 26.03 Mn
Dec 31, 2018 26.20 Mn
Sep 30, 2018 25.43 Mn
Jun 30, 2018 15.81 Mn
Mar 31, 2018 9.83 Mn
Dec 31, 2017 6.80 Mn
Sep 30, 2017 5.39 Mn
Jun 30, 2017 4.43 Mn
Mar 31, 2017 4.76 Mn
Dec 31, 2016 4.91 Mn
Sep 30, 2016 3.84 Mn
Jun 30, 2016 4.22 Mn
Mar 31, 2016 4.26 Mn
Dec 31, 2015 4.27 Mn
Sep 30, 2015 4.23 Mn
Jun 30, 2015 4.42 Mn
Mar 31, 2015 4.71 Mn
Dec 31, 2014 4.31 Mn
Sep 30, 2014 4.34 Mn
Jun 30, 2014 4.78 Mn
Mar 31, 2014 4.72 Mn
Dec 31, 2013 3.59 Mn
Sep 30, 2013 3.86 Mn
Jun 30, 2013 4.24 Mn
Mar 31, 2013 3.79 Mn
Dec 31, 2012 3.88 Mn
Sep 30, 2012 2.30 Mn
Jun 30, 2012 2.21 Mn
Mar 31, 2012 2.13 Mn
Dec 31, 2011 1.62 Mn
Sep 30, 2011 965,000.00
Jun 30, 2011 759,000.00
Mar 31, 2011 471,000.00